Efficacy and safety of tezepelumab in patients with uncontrolled disease while receiving maintenance therapy for moderate or severe asthma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy and safety of tezepelumab in patients with uncontrolled disease while receiving maintenance therapy for moderate or severe asthma

Published:2023-03 Issue:3 Volume:11 Page:943-945.e2
ISSN:2213-2198
Container-title:The Journal of Allergy and Clinical Immunology: In Practice
language:en
Short-container-title:The Journal of Allergy and Clinical Immunology: In Practice

Author:

Corren Jonathan,Wechsler Michael E.,Chupp Geoffrey,Roseti Stephanie L.,Hellqvist Åsa,Martin Neil,Llanos Jean-Pierre,Ambrose Christopher S.,Colice Gene

Funder

Amgen

AstraZeneca

Publisher

Elsevier BV

Subject

Immunology and Allergy

Reference6 articles.

1. Significant variability in response to inhaled corticosteroids for persistent asthma;Szefler;J Allergy Clin Immunol,2002

2. Relative efficacy and safety of inhaled corticosteroids in patients with asthma: systematic review and network meta-analysis;Chipps;Ann Allergy Asthma Immunol,2020

3. Thymic stromal lymphopoietin: its role and potential as a therapeutic target in asthma;Gauvreau;Expert Opin Ther Targets,2020

4. Tezepelumab in adults and adolescents with severe, uncontrolled asthma;Menzies-Gow;N Engl J Med,2021

5. Tezepelumab in adults with uncontrolled asthma;Corren;N Engl J Med,2017

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An overview of the preclinical discovery and development of tezepelumab for the treatment of asthma;Expert Opinion on Drug Discovery;2023-06-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP